Statement: no cardiac or neural adverse events were recorded in the primary trial. exposure reference identifier is a character or string used to name, or characterize an exposure reference.
Primary_evidence: Adverse Events 1:   Total: 2/30 (6.67%)   Dry Eyes  [1]1/30 (3.33%)   Diarrhea  [2]1/30 (3.33%)